Clinical Study
Evaluation of Clinical and Ultrasonographic Parameters in Psoriatic Arthritis Patients Treated with Adalimumab: A Retrospective Study
Table 1
Patients demographics and disease characteristics at baseline.
| Number of patients | 40 | Male/female | 21/19 | Age, (mean ± SD) | 51.5 ± 10.3 | Duration of disease | | Psoriasis (mean ± SD) | 22.2 ± 11.5 | Psoriatic arthritis (mean ± SD) | 10.7 ± 7.7 | PASI (mean ± SD) | 9.2 ± 10.8 | Pain VAS (mean ± SD) | 65 ± 21.3 | DAS 28 (mean ± SD) | 4.6 ± 1.5 | ESR (mean ± SD) | 34.7 ± 21.6 | CRP (mean ± SD) | 20.8 ± 16.4 | Age of onset (mean ± SD) | | Psoriasis (mean ± SD) | 29.3 ± 16.5 | Psoriatic arthritis (mean ± SD) | 40.8 ± 12.2 | Previous methotrexate treatment | 31 (77.5%) | Previous ciclosporin treatment | 35 (87.5%) | Previous pUVA-UVB treatment | 14 (35%) | Previous leflunomide treatment | 17 (42.5%) | Previous sulphasalazine treatment | 12 (30%) |
|
|